Loading…
Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg Lithium Carbonate Sustained Release Tablets USP 400mg
Categories: , , , ,
Date:

Lithium Carbonate Sustained Release Tablets USP 400mg Technical Specification:

Product Name:Lithium Carbonate Sustained Release Tablets USP 400mg
Brand Name:Generic
Strength:300mg, 400mg
Dosage Form:Tablets (Film-coated)
Route of Administration:Via Oral Route
Packing:2s, 10s, 30s, 100s
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Antidepressants, Central nervous system
Indication: Lithium Carbonate is used to treat manic-depressive disorder (bipolar disorder).
Storage:Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

GENERIC NAME OF THE MEDICINAL PRODUCT:

  •  Lithium Carbonate Sustained Release Tablets USP 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Lithium Carbonate Sustained Release Tablets USP 400mg
    Each sustained release tablet contains:
    Lithium Carbonate USP…………………400mg
    Excipients………………………………………q.s.

THERAPEUTIC INDICATIONS:

Lithium Carbonate is used to treat manic-depressive disorder (bipolar disorder). It works to stabilize the mood and reduce extremes in behavior by restoring the balance of certain natural substances (neurotransmitters) in the brain.

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH

Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Store the unit-dose blister pack in this bottle with the cap tightly secured till both tablets have been consumed.
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

Dosage: As directed by the Physician

Attach dispensing label as per end country.

GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Lithium Carbonate Sustained Release Tablets USP 300mg
B) Lithium Carbonate Sustained Release Tablets USP 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Lithium Carbonate Sustained Release Tablets USP 300mg
Each sustained release tablet contains:
Lithium Carbonate USP………………300mg
Excipients……………………………………q.s.

B) Lithium Carbonate Sustained Release Tablets USP 400mg
Each sustained release tablet contains:
Lithium Carbonate USP…………………400mg
Excipients………………………………………q.s.

THERAPEUTIC INDICATIONS:

Lithium Carbonate is used to treat manic-depressive disorder (bipolar disorder). It works to stabilize the mood and reduce extremes in behavior by restoring the balance of certain natural substances (neurotransmitters) in the brain.

CAUTION & WARNING:

CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Store the unit-dose blister pack in this bottle with the cap tightly secured till both tablets have been consumed.
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Dosage: As directed by the Physician